CytomX Therapeutics, Inc. earnings per share and revenue

CTMX earnings per share for the last quarter are -0.08 USD whereas the estimation was -0.10 USD which accounts for 19.84% surprise. Company revenue for the same period amounts to 25.11 M USD despite the estimated figure of 20.00 M USD. Estimated earnings per share for the next quarter are -0.17 USD, and revenue is expected to reach 17.10 M USD. Also watch annual changes over time to get a bigger picture of CTMX earnings per share and revenue dynamics.